Shareholders Foundation, Inc.

Boston Scientific Corporation (NYSE:BSX) Investor Alert: Investigation over Possible Violations of Securities Laws

An investigation for investors in Boston Scientific Corporation (NYSE:BSX) shares over potential securities laws violations by Boston Scientific was announced and NYSE:BSX stockholders should contact the Shareholders Foundation.

 

San Diego, CA -- (SBWIRE) -- 08/12/2014 -- An investigation on behalf of investors of Boston Scientific Corporation (NYSE:BSX shares over potential securities laws violations by Boston Scientific and certain of its directors and officers in connection certain financial statements was announced.

If you purchased shares of Boston Scientific Corporation (NYSE:BSX), you have certain options and you should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Boston Scientific Corporation (NYSE:BSX) concerning whether a series of statements by Boston Scientific regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Boston Scientific Corporation reported that while its annual Total Revenue declined from over $7.24 billion in 2012 to over $7.14 billion in 2013, its Net Loss of over $4.06 billion in 2012 decreased to $121 million in 2013. Shares of Boston Scientific Corporation (NYSE:BSX) grew from $5.15 per share in November 2012 to as high as $13.98 per share in January 2014.

Then on August 7, 2014, Boston Scientific Corporation disclosed that in July 2014 it was served with a subpoena from the U.S. Attorney for the District of New Jersey and that the subpoena seeks information relating to BridgePoint Medical, Inc., which Boston Scientific Corporation acquired in October 2012, including information relating to its sale of CrossBoss and Stingray products, educational and training activities that relate to those sales and it acquisition of BridgePoint Medical. Shares of Boston Scientific Corporation (NYSE:BSX) declined to as low as $12.03 per share on August 8, 2014.

Those who purchased shares of Boston Scientific Corporation (NYSE:BSX) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com